FDA Drug recall D-0012-2018
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
- FDA Drug
- Class II
- terminated
- Published 2017-10-25
On 2017-10-25 the FDA classified a Class II recall of methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10 by Rxq Compounding, citing lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0012-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-09-25 |
| Published | 2017-10-25 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Rxq Compounding |
| Distribution | FL, LA, MA, OH, PA, TX |
Product
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
Reason
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Identifiers
| code_info | Lot: 04252017@1, exp 5/9/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0012-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.